Cardiac Mechanical Performance Assessment at Different Levels of Exercise in Childhood Acute Lymphoblastic Leukemia Survivors.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
received:
24
09
2022
accepted:
31
03
2023
medline:
26
6
2023
pubmed:
6
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
There is a shortage of relevant studies interested in cardiac mechanical performance. Thus, it is clinically relevant to study the impact of cancer treatments on survivors' cardiac mechanical performance to improve our knowledge. The first objective of this study is to assess survivors' cardiac mechanical performance during a cardiopulmonary exercise test (CPET) using both ventricular-arterial coupling (VAC) and cardiac work efficiency (CWE) from cardiac magnetic resonance (CMR) acquisitions. The second objective is to assess the impact of doxorubicin and dexrazoxane (DEX) treatments. A total of 63 childhood acute lymphoblastic leukemia survivors underwent a CMR at rest on a 3T magnetic resonance imaging system, followed by a CPET on ergocycle. The CircAdapt model was used to study cardiac mechanical performance. At different levels of exercise, arterial elastance, end-systolic elastance, VAC, and CWE were estimated. We observed significant differences between the different levels of exercise for both VAC ( P <0.0001) and CWE parameters ( P =0.001). No significant differences were reported between prognostic risk groups at rest and during the CPET. Nevertheless, we observed that survivors in the SR group had a VAC value slightly lower than heart rate (HR)+DEX and HR groups throughout the CPET. Moreover, survivors in the SR group had a CWE parameter slightly higher than HR+DEX and HR groups throughout the CPET. This study reveals that the combination of CPET, CMR acquisitions and CircAdapt model was sensitive enough to observe slight changes in the assessment of VAC and CWE parameters. Our study contributes to improving survivors' follow-up and detection of cardiac problems induced by doxorubicin-related cardiotoxicity.
Sections du résumé
BACKGROUND
BACKGROUND
There is a shortage of relevant studies interested in cardiac mechanical performance. Thus, it is clinically relevant to study the impact of cancer treatments on survivors' cardiac mechanical performance to improve our knowledge. The first objective of this study is to assess survivors' cardiac mechanical performance during a cardiopulmonary exercise test (CPET) using both ventricular-arterial coupling (VAC) and cardiac work efficiency (CWE) from cardiac magnetic resonance (CMR) acquisitions. The second objective is to assess the impact of doxorubicin and dexrazoxane (DEX) treatments.
METHODS
METHODS
A total of 63 childhood acute lymphoblastic leukemia survivors underwent a CMR at rest on a 3T magnetic resonance imaging system, followed by a CPET on ergocycle. The CircAdapt model was used to study cardiac mechanical performance. At different levels of exercise, arterial elastance, end-systolic elastance, VAC, and CWE were estimated.
RESULTS
RESULTS
We observed significant differences between the different levels of exercise for both VAC ( P <0.0001) and CWE parameters ( P =0.001). No significant differences were reported between prognostic risk groups at rest and during the CPET. Nevertheless, we observed that survivors in the SR group had a VAC value slightly lower than heart rate (HR)+DEX and HR groups throughout the CPET. Moreover, survivors in the SR group had a CWE parameter slightly higher than HR+DEX and HR groups throughout the CPET.
CONCLUSIONS
CONCLUSIONS
This study reveals that the combination of CPET, CMR acquisitions and CircAdapt model was sensitive enough to observe slight changes in the assessment of VAC and CWE parameters. Our study contributes to improving survivors' follow-up and detection of cardiac problems induced by doxorubicin-related cardiotoxicity.
Identifiants
pubmed: 37278566
doi: 10.1097/MPH.0000000000002682
pii: 00043426-202307000-00004
doi:
Substances chimiques
Doxorubicin
80168379AG
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
247-255Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Kakaje A, Alhalabi MM, Ghareeb A, et al. Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep. 2020;10:6756.
Schuz J, Erdmann F. Environmental exposure and risk of childhood leukemia: an overview. Arch Med Res. 2016;47:607–614.
Kizilocak H, Okcu F. Late effects of therapy in childhood acute lymphoblastic leukemia survivors. Turk J Haematol. 2019;36:1–11.
Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–1552.
Wenningmann N, Knapp M, Ande A, et al. Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring. Mol Pharmacol. 2019;96:219–232.
Moazeni S, Cadeiras M, Yang EH, et al. Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care. Clin Transl Med. 2017;6:17.
Bansal N, Amdani SM, Hutchins KK, et al. Cardiovascular disease in survivors of childhood cancer. Curr Opin Pediatr. 2018;30:628–638.
Kang Y, Assuncao BL, Denduluri S, et al. Symptomatic heart failure in acute leukemia patients treated with anthracyclines. JACC CardioOncol. 2019;1:208–217.
Caru M, Corbin D, Perie D, et al. Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors. Clin Res Cardiol. 2019;108:1000–1008.
Mancilla TR, Iskra B, Aune GJ. Doxorubicin-Induced Cardiomyopathy in Children. Compr Physiol. 2019;9:905–931.
Bansal N, Adams MJ, Ganatra S, et al. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors. Cardiooncology. 2019;5:18.
Caru M, Samoilenko M, Drouin S, et al. Childhood acute lymphoblastic leukemia survivors have a substantially lower cardiorespiratory fitness level than healthy Canadians despite a clinically equivalent level of physical activity. J Adolesc Young Adult Oncol. 2019;8:674–683.
Lemay V, Caru M, Samoilenko M, et al. Physical activity and sedentary behaviors in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol. 2020;42:53–60.
Lemay V, Caru M, Samoilenko M, et al. Prevention of long-term adverse health outcomes with cardiorespiratory fitness and physical activity in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol. 2018;41:e450–e458.
Vigorito C, Giallauria F. Effects of exercise on cardiovascular performance in the elderly. Front Physiol. 2014;5:51.
Caru M, Laverdière C, Lemay V, et al. Maximal cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors exposed to chemotherapy. Support Care Cancer. 2021;29:987–996.
Zhou Y, Zhu J, Gu Z, et al. Efficacy of exercise interventions in patients with acute leukemia: a meta-analysis. PLoS One. 2016;11:e0159966.
Nguyen M, Berhoud V, Bartamian L, et al. Agreement between different non-invasive methods of ventricular elastance assessment for the monitoring of ventricular-arterial coupling in intensive care. J Clin Monit Comput. 2020;34:893–901.
Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol (1985). 2008;105:1342–1351.
Cohen-Solal A, Faraggi M, Czitrom D, et al. Left ventricular-arterial system coupling at peak exercise in dilated nonischemic cardiomyopathy. Chest. 1998;113:870–877.
Sulicka-Grodzicka J, Chyrchel B, Toton-Zuranska J, et al. Cranial irradiation in childhood acute lymphoblastic leukemia is related to subclinical left ventricular dysfunction and reduced large artery compliance in cancer survivors. J Clin Med. 2019;8:1952.
Aslanger E, Assous B, Bihry N, et al. Effects of cardiopulmonary exercise rehabilitation on left ventricular mechanical efficiency and ventricular-arterial coupling in patients with systolic heart failure. J Am Heart Assoc. 2015;4:e002084.
Godfrey ME, Rathod RH, Keenan E, et al. Inefficient ventriculoarterial coupling in fontan patients: a cardiac magnetic resonance study. Pediatr Cardiol. 2018;39:763–773.
Chantler PD. Arterial ventricular uncoupling with age and disease and recoupling with exercise. Exerc Sport Sci Rev. 2017;45:70–79.
Koelwyn GJ, Lewis NC, Ellard SL, et al. Ventricular-arterial coupling in breast cancer patients after treatment with anthracycline-containing adjuvant chemotherapy. Oncologist. 2016;21:141–149.
Silverman LB, Stevenson KE, O’Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia. 2010;24:320–334.
Marcoux S, Drouin S, Laverdiere C, et al. The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer. 2017;64:1–8.
Bar-Or O, Rowland TW. Pediatric Exercise Medicine: from Physiologic Principles to Health Care Application. Human Kinetics; 2004.
Paridon SM, Alpert BS, Boas SR, et al. Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation. 2006;113:1905–1920.
Buchfuhrer MJ, Hansen JE, Robinson TE, et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:1558–1564.
Charloux A, Lonsdorfer-Wolf E, Richard R, et al. A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: comparison with the “direct” Fick method. Eur J Appl Physiol. 2000;82:313–320.
Richard R, Lonsdorfer-Wolf E, Charloux A, et al. Non-invasive cardiac output evaluation during a maximal progressive exercise test, using a new impedance cardiograph device. Eur J Appl Physiol. 2001;85:202–207.
Welsman J, Bywater K, Farr C, et al. Reliability of peak VO(2) and maximal cardiac output assessed using thoracic bioimpedance in children. Eur J Appl Physiol. 2005;94:228–234.
James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858.
Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–2274.
Arts T, Delhaas T, Bovendeerd P, et al. Adaptation to mechanical load determines shape and properties of heart and circulation: the CircAdapt model. Am J Physiol Heart Circ Physiol. 2005;288:H1943–H1954.
Lumens J, Fan CS, Walmsley J, et al. Relative impact of right ventricular electromechanical dyssynchrony versus pulmonary regurgitation on right ventricular dysfunction and exercise intolerance in patients after repair of tetralogy of fallot. J Am Heart Assoc. 2019;8:e010903.
Lumens J, Delhaas T. Cardiovascular modeling in pulmonary arterial hypertension: focus on mechanisms and treatment of right heart failure using the CircAdapt model. Am J Cardiol. 2012;110(6 Suppl):39S–48S.
Hau EM, Caccia JN, Kasteler R, et al. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study. Swiss Med Wkly. 2019;149:w20012.
Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501–H512.
Shoucri RM. Calculation of parameters of end-systolic pressure–volume relation in the ventricles. Math Comput Model. 2011;54:1638–43.
Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063–1093.
Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail. 2019;21:402–424.
Antonini-Canterin F, Poli S, Vriz O, et al. The ventricular-arterial coupling: from basic pathophysiology to clinical application in the echocardiography laboratory. J Cardiovasc Echogr. 2013;23:91–95.
Narayan HK, French B, Khan AM, et al. Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics-related cardiac dysfunction. JACC Cardiovasc Imaging. 2016;9:1131–1141.
Bastos MB, Burkhoff D, Maly J, et al. Invasive left ventricle pressure-volume analysis: overview and practical clinical implications. Eur Heart J. 2020;41:1286–1297.
El Mahdiui M, van der Bijl P, Abou R, et al. Global left ventricular myocardial work efficiency in healthy individuals and patients with cardiovascular disease. J Am Soc Echocardiogr. 2019;32:1120–1127.
Papadopoulos K, Ozden Tok O, Mitrousi K, et al. Myocardial work: methodology and clinical applications. Diagnostics (Basel). 2021;11:573.
Najjar SS, Schulman SP, Gerstenblith G, et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol. 2004;44:611–617.
Clemmensen TS, Eiskjaer H, Mikkelsen F, et al. Left ventricular pressure-strain-derived myocardial work at rest and during exercise in patients with cardiac amyloidosis. J Am Soc Echocardiogr. 2020;33:573–582.
Willemen E, Schreurs R, Huntjens PR, et al. The left and right ventricles respond differently to variation of pacing delays in cardiac resynchronization therapy: a combined experimental-computational approach. Front Physiol. 2019;10:17.